According to the 16th edition of Deloittes annual Measuring the Return from Pharmaceutical Innovation report, which is tellingly titled Navigating the GLP-1 boom, the projected internal rate of return on late-stage pipeline assets rose for the third consecutive year, hitting 7.0% in 2025
That may offer more customization
Still, preventing GLP-2-mediated increases in portal and intestinal blood flow via L-NAME, blocks the GLP-2-mediated increase in apoB48 in the TRL fraction of plasma (Hsieh et al., 2015)
1 For a complete list of potential side effects, visit: What should I do if I miss a dose
WHY FIBER, GENERIC PROBIOTICS, AND STOOL SOFTENERS DON'T WORK ON A GLP-1 Fiber supplements add bulk to an already-stalled system, making bloating worse